SCIENCE OF
POSSIBILITY
At Vertex, we invest in scientific innovation to create transformative medicines for people with serious diseases.
We announced new data on our CRISPR/Cas9 gene-edited treatment at the 2024 American Society of Hematology Annual Meeting
We report third quarter 2024 financial results
Vertex to share new data from multiple investigational kidney disease programs at the 2024 American Society of Nephrology Kidney Week Congress
We announced that we will present pivotal Phase 3 data about our investigational pain program at the annual meeting of the American Society of Anesthesiologists
We are presenting new data on our cystic fibrosis medicines at the 2024 North American Cystic Fibrosis Conference
Working at Vertex
Our company is built on an inclusive culture that brings together the best and brightest in every field striving for one goal: to improve the lives of people with serious diseases.
Find a Vertex clinical trial
Volunteers who participate in clinical trials
help make new medicines a reality.
Featured stories